The TAGGS Assistance Listing Report provides detailed award information for a single Assistance Listing. The data provided is from FY 2008 or from the start date of data collection through the present. For information prior to FY 2008, please use the TAGGS Advanced Search.
In the top display you will see the name of the Assistance Listing, agency, assistance type, and any popular name it might use, along with the 5-digit CFDA number.
Assistance Listings consisting of Direct Payment Awards may not contain links to additional recipient and award information. Direct Payment data is often collected as aggregated payments to a state to protect the personal information of the assistance recipients.
Along with the bar chart broken up by Issue Date or Funding Fiscal Year, there is also an exportable table below that groups by Issue Date or Funding Fiscal Year and shows the recipient name, state, award number, award title and amount from each award action.
By using the radio buttons, you may view data by the Issue Date Fiscal Year of by Funding Fiscal Year. In most cases, the Issue Date and Funding Fiscal Years coincide, although in some cases, delays in issuing an award and award close outs will cause the Issue Date of an award to be outside the of the Funding Fiscal Year.
Table data can be exported by choosing one of the export-format icons located at the top right of the table. Export file formats include:
The two Fiscal Year (FY) viewing options are:
|Issue Date FY||The FY in which the award action Occurred|
|Funding FY||The FY in which the award action Funded|
To enter Keyboard Support and Web Page Reader Support for the report results grid view, you will need to press Ctrl Shift G
|Move through rows||← ↑ ↓ →|
|Next page||SHIFT PAGE DOWN|
|Previous page||SHIFT PAGE UP|
|Move through column headers and data fields||TAB|
|Sort ASC/DESC when a column header is selected||ENTER|
Objectives: To encourage basic and clinical biomedical research and research training for a greater understanding of the basic mechanisms underlying biologic processes and diseases in the nephrologic, urologic, and hematologic systems. These include studies on immune mechanisms of kidney disease; effects of drugs, nephrotoxins and environmental toxins on the kidney; and the structure and function of the kidney such as metabolism, transport, and fluid-electrolyte dynamics. Of special interest is the pathophysiology of chronic renal failure and endstage renal disease as well as renal transplantation and maintenance dialysis therapies (hemodialysis and peritoneal dialysis as examples). In urology research to encourage biomedical research in lower urinary tract physiology and pathophysiology, including neuromuscular, mechanisms, i.e., bladder dysfunction, incontinence, pyelonephritis, interstitial cystitis, benign prostatic hyperplasia, and vesicoureteral and renal reflux. In hematologic research, to encourage biomedical research in the etiology, pathogenesis, and therapeutic modalities of the anemias of chronic renal failure and other chronic diseases; bone marrow transplantation; erythropoietin involvement in regulation of stem cell differentiation; metabolism of iron overload and deficiency; and the structure, biosynthesis and genetic regulation of hemoglobin. To extramurally support basic laboratory research and clinical investigations and provide postdoctoral biomedical research training for individuals interested in careers in health sciences and fields related to these programs. Small Business Innovation Research (SBIR) program: To expand and improve the SBIR Program; to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-ow